Y10S 977/904
For medical, immunological, body treatment, or diagnosis
Official title: for medical, immunological, body treatment, or diagnosis
Y10S977/904 (For medical, immunological, body treatment, or diagnosis) appears on 2,123 US grants and 1,604 published applications in this corpus.
Search patents in Y10S- Granted patents
- 2,123
- Published applications
- 1,604
- Assignees
- 1,056
- Inventors
- 3,861
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 4 | 0 |
| 1988 | 2 | 0 |
| 1989 | 4 | 0 |
| 1990 | 1 | 0 |
| 1991 | 6 | 0 |
| 1992 | 8 | 0 |
| 1993 | 1 | 0 |
| 1994 | 14 | 0 |
| 1995 | 20 | 0 |
| 1996 | 48 | 0 |
| 1997 | 62 | 0 |
| 1998 | 87 | 0 |
| 1999 | 120 | 0 |
| 2000 | 103 | 0 |
| 2001 | 142 | 30 |
| 2002 | 158 | 163 |
| 2003 | 228 | 131 |
| 2004 | 72 | 96 |
| 2005 | 52 | 71 |
| 2006 | 49 | 76 |
| 2007 | 45 | 75 |
| 2008 | 37 | 52 |
| 2009 | 47 | 78 |
| 2010 | 65 | 61 |
| 2011 | 74 | 70 |
| 2012 | 65 | 73 |
| 2013 | 57 | 127 |
| 2014 | 87 | 85 |
| 2015 | 99 | 75 |
| 2016 | 81 | 72 |
| 2017 | 62 | 79 |
| 2018 | 43 | 55 |
| 2019 | 46 | 43 |
| 2020 | 43 | 23 |
| 2021 | 38 | 28 |
| 2022 | 15 | 17 |
| 2023 | 11 | 7 |
| 2024 | 9 | 7 |
| 2025 | 9 | 6 |
| 2026 | 3 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- Y10S 977/906Drug delivery767
- Y10S 977/915Therapeutic or pharmaceutical composition550
- Y10S 977/924Using nanostructure as support of dna analysis269
- Y10S 977/92Detection of biochemical252
- Y10S 977/927Diagnostic contrast agent231
- Y10S 977/926Topical chemical167
- Y10S 977/908Mechanical repair performed/surgical147
- Y10S 977/918Immunological141
Recent patents
- Non-enzymatic glucose-sensing device with nanoporous structure and conditioning of the nanoporous structure8 Sep 2026US 12,727,800 B2UXN Co., Ltd.
- Analyte sequencing with nanopores21 Jul 2026US 12,687,517 B2University of Washington
- Glucose-sensing device with maltose blocking layer19 May 2026US 12,629,064 B2UXN Co., Ltd.
- Glucose sensor apparatus addressing interference of ascorbic acid and acetaminophen14 Oct 2025US 12,440,131 B2UXN Co., Ltd.
- Ultra-sensitive detection method using photoluminescent particles26 Aug 2025US 12,399,124 B2Centre National De La Recherche Scientifique
- Methods of improving the solubility and bioavailability of therapeutic agents10 Sep 2026US 2026/0263380 A1MAA Laboratories, Inc.
- Surface functionalized, host-guest polymer nano-assemblies and methods thereof20 Aug 2026US 2026/0240786 A1University of Massachusetts
- Non-enzymatic glucose-sensing device with nanoporous structure and conditioning of the nanoporous structure18 Jun 2026US 2026/0165622 A1UXN Co., Ltd.
- Glucose sensor apparatus addressing interference of ascorbic acid and acetaminophen8 Jan 2026US 2026/0007341 A1UXN Co., Ltd.
- Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery11 Sep 2025US 2025/0281417 A1The Regents of the University of California
Most cited
By later US patents
- Wearable, self-contained drug infusion device1,559US 6,589,229 B1Becton, Dickinson and Company · 2003
- Electrochemical cell sensor for continuous short-term use in tissues and blood1,520US 4,671,288 AThe Regents of the University of California · 1987
- Mass transport limited in vivo analyte sensor1,471US 6,654,625 B1TheraSense, Inc. · 2003
- Mesoscale polynucleotide amplification device and method1,042US 5,498,392 AThe Trustees of the University of Pennsylvania · 1996
- Methods and apparatus for the detection of an analyte utilizing mesoscale flow systems1,006US 5,637,469 AThe Trustees of the University of Pennsylvania · 1997